Annual accounts receivable:
$1.87B-$231.20M(-11.01%)Summary
- As of today (June 7, 2025), BIIB annual accounts receivable is $1.87 billion, with the most recent change of -$231.20 million (-11.01%) on December 31, 2024.
- During the last 3 years, BIIB annual accounts receivable has fallen by -$92.90 million (-4.74%).
- BIIB annual accounts receivable is now -24.81% below its all-time high of $2.49 billion, reached on December 31, 2018.
Performance
BIIB Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$2.00B+$127.70M(+6.83%)Summary
- As of today (June 7, 2025), BIIB quarterly accounts receivable is $2.00 billion, with the most recent change of +$127.70 million (+6.83%) on March 31, 2025.
- Over the past year, BIIB quarterly accounts receivable has dropped by -$3.20 million (-0.16%).
- BIIB quarterly accounts receivable is now -23.68% below its all-time high of $2.62 billion, reached on March 31, 2019.
Performance
BIIB Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BIIB Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.0% | -0.2% |
| 3 y3 years | -4.7% | -1.2% |
| 5 y5 years | -24.4% | -23.3% |
BIIB Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.5% | at low | -9.7% | +6.8% |
| 5 y | 5-year | -24.4% | at low | -23.3% | +6.8% |
| alltime | all time | -24.8% | >+9999.0% | -23.7% | >+9999.0% |
BIIB Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.00B(+6.8%) |
| Dec 2024 | $1.87B(-11.0%) | $1.87B(-6.0%) |
| Sep 2024 | - | $1.99B(-4.3%) |
| Jun 2024 | - | $2.08B(+3.9%) |
| Mar 2024 | - | $2.00B(-4.8%) |
| Dec 2023 | $2.10B(-1.7%) | $2.10B(-5.0%) |
| Sep 2023 | - | $2.21B(+4.0%) |
| Jun 2023 | - | $2.12B(+4.7%) |
| Mar 2023 | - | $2.03B(-5.1%) |
| Dec 2022 | $2.14B(+8.9%) | $2.14B(+7.7%) |
| Sep 2022 | - | $1.98B(-1.0%) |
| Jun 2022 | - | $2.00B(-0.9%) |
| Mar 2022 | - | $2.02B(+3.0%) |
| Dec 2021 | $1.96B(-15.7%) | $1.96B(-7.6%) |
| Sep 2021 | - | $2.12B(+0.6%) |
| Jun 2021 | - | $2.11B(-5.1%) |
| Mar 2021 | - | $2.22B(-4.4%) |
| Dec 2020 | $2.33B(-5.8%) | $2.33B(-8.8%) |
| Sep 2020 | - | $2.55B(-0.9%) |
| Jun 2020 | - | $2.57B(-1.1%) |
| Mar 2020 | - | $2.60B(+5.4%) |
| Dec 2019 | $2.47B(-0.6%) | $2.47B(-1.8%) |
| Sep 2019 | - | $2.52B(-0.1%) |
| Jun 2019 | - | $2.52B(-3.8%) |
| Mar 2019 | - | $2.62B(+5.3%) |
| Dec 2018 | $2.49B(+7.1%) | $2.49B(-1.6%) |
| Sep 2018 | - | $2.53B(+3.8%) |
| Jun 2018 | - | $2.43B(-2.4%) |
| Mar 2018 | - | $2.49B(+7.5%) |
| Dec 2017 | $2.32B(+33.1%) | $2.32B(+11.2%) |
| Sep 2017 | - | $2.09B(-2.2%) |
| Jun 2017 | - | $2.13B(+16.8%) |
| Mar 2017 | - | $1.83B(+4.8%) |
| Dec 2016 | $1.74B(+13.0%) | $1.74B(-1.7%) |
| Sep 2016 | - | $1.77B(+9.0%) |
| Jun 2016 | - | $1.63B(-4.9%) |
| Mar 2016 | - | $1.71B(+10.9%) |
| Dec 2015 | $1.54B(+19.3%) | $1.54B(+16.1%) |
| Sep 2015 | - | $1.33B(+1.3%) |
| Jun 2015 | - | $1.31B(-5.7%) |
| Mar 2015 | - | $1.39B(+7.6%) |
| Dec 2014 | $1.29B(+56.8%) | $1.29B(+18.4%) |
| Sep 2014 | - | $1.09B(+8.9%) |
| Jun 2014 | - | $1.00B(-1.6%) |
| Mar 2014 | - | $1.02B(+23.5%) |
| Dec 2013 | $824.41M(+20.0%) | $824.41M(-7.5%) |
| Sep 2013 | - | $891.40M(+3.5%) |
| Jun 2013 | - | $861.46M(+14.3%) |
| Mar 2013 | - | $753.61M(+9.7%) |
| Dec 2012 | $686.85M(+17.5%) | $686.85M(+3.8%) |
| Sep 2012 | - | $661.52M(-3.3%) |
| Jun 2012 | - | $683.84M(-0.1%) |
| Mar 2012 | - | $684.24M(+17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $584.60M(-3.4%) | $584.60M(+0.6%) |
| Sep 2011 | - | $581.05M(-12.9%) |
| Jun 2011 | - | $666.96M(-3.0%) |
| Mar 2011 | - | $687.61M(+13.6%) |
| Dec 2010 | $605.33M(+9.8%) | $605.33M(-1.8%) |
| Sep 2010 | - | $616.70M(+12.4%) |
| Jun 2010 | - | $548.89M(-2.1%) |
| Mar 2010 | - | $560.78M(+1.7%) |
| Dec 2009 | $551.21M(+23.4%) | $551.21M(+0.0%) |
| Sep 2009 | - | $551.00M(+7.8%) |
| Jun 2009 | - | $511.29M(+6.2%) |
| Mar 2009 | - | $481.21M(+7.7%) |
| Dec 2008 | $446.67M(+13.8%) | $446.67M(-7.8%) |
| Sep 2008 | - | $484.64M(+0.4%) |
| Jun 2008 | - | $482.80M(+6.9%) |
| Mar 2008 | - | $451.48M(+15.0%) |
| Dec 2007 | $392.65M(+23.7%) | $392.65M(+3.7%) |
| Sep 2007 | - | $378.81M(+5.4%) |
| Jun 2007 | - | $359.52M(+10.8%) |
| Mar 2007 | - | $324.57M(+2.3%) |
| Dec 2006 | $317.35M(+13.1%) | $317.35M(+12.3%) |
| Sep 2006 | - | $282.52M(-0.8%) |
| Jun 2006 | - | $284.91M(+3.1%) |
| Mar 2006 | - | $276.44M(-1.5%) |
| Dec 2005 | $280.51M(+0.7%) | $280.51M(+7.3%) |
| Sep 2005 | - | $261.54M(+3.0%) |
| Jun 2005 | - | $254.01M(-7.6%) |
| Mar 2005 | - | $275.01M(-1.3%) |
| Dec 2004 | $278.64M(+40.4%) | $278.64M(+17.3%) |
| Sep 2004 | - | $237.57M(+13.5%) |
| Jun 2004 | - | $209.28M(+3.9%) |
| Mar 2004 | - | $201.37M(+1.4%) |
| Dec 2003 | $198.52M(+3935.0%) | $198.52M(-6.2%) |
| Sep 2003 | - | $211.75M(+7.4%) |
| Jun 2003 | - | $197.15M(+10.8%) |
| Mar 2003 | - | $177.97M(+3517.2%) |
| Dec 2002 | $4.92M(-97.2%) | $4.92M(-96.9%) |
| Sep 2002 | - | $158.18M(-13.0%) |
| Jun 2002 | - | $181.90M(+5.2%) |
| Mar 2002 | - | $172.94M(-2.6%) |
| Dec 2001 | $177.58M(+24.0%) | $177.58M(+11.7%) |
| Sep 2001 | - | $159.00M(-4.5%) |
| Jun 2001 | - | $166.46M(+13.4%) |
| Mar 2001 | - | $146.80M(+2.5%) |
| Dec 2000 | $143.18M(+4.2%) | $143.18M(-1.7%) |
| Sep 2000 | - | $145.69M(-5.6%) |
| Jun 2000 | - | $154.30M(+13.9%) |
| Mar 2000 | - | $135.49M(-1.4%) |
| Dec 1999 | $137.36M(+35.6%) | $137.36M(+35.6%) |
| Dec 1998 | $101.28M(+16.7%) | $101.28M(+16.7%) |
| Dec 1997 | $86.80M(+102.1%) | $86.80M(+102.1%) |
| Dec 1996 | $42.95M(+119.0%) | $42.95M(+119.0%) |
| Dec 1995 | $19.61M(+6.0%) | $19.61M(+6.0%) |
| Dec 1994 | $18.50M | $18.50M |
FAQ
- What is Biogen annual accounts receivable?
- What is the all time high annual accounts receivable for Biogen?
- What is Biogen annual accounts receivable year-on-year change?
- What is Biogen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Biogen?
- What is Biogen quarterly accounts receivable year-on-year change?
What is Biogen annual accounts receivable?
The current annual accounts receivable of BIIB is $1.87B
What is the all time high annual accounts receivable for Biogen?
Biogen all-time high annual accounts receivable is $2.49B
What is Biogen annual accounts receivable year-on-year change?
Over the past year, BIIB annual accounts receivable has changed by -$231.20M (-11.01%)
What is Biogen quarterly accounts receivable?
The current quarterly accounts receivable of BIIB is $2.00B
What is the all time high quarterly accounts receivable for Biogen?
Biogen all-time high quarterly accounts receivable is $2.62B
What is Biogen quarterly accounts receivable year-on-year change?
Over the past year, BIIB quarterly accounts receivable has changed by -$3.20M (-0.16%)